Hemodynamic Monitoring Systems Market Size Share Trends Forecast 2027


Posted March 24, 2021 by SANJAYCMI

“Coherent Market Insights “HEMODYNAMIC MONITORING SYSTEMS MARKET – GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027″
 
Global Hemodynamic Monitoring System Market: Drivers

Increasing prevalence of congenital heart disease is expected to propel growth of the global Hemodynamic Monitoring System Market over the forecast period. For instance, according to the study, Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study (published in May 2018), the prevalence of congenital heart disease (CHD) was 10.13/1000 live births.

Hemodynamic monitoring systems are used in hospitals, clinics, home care settings, ambulatory surgery centers, and independent catheterization laboratories. Some of these systems include, vital sign monitors, pulse oximeters, central venous catheters, non-invasive blood pressure monitors, and pulmonary artery catheters. The global hemodynamic monitoring system market is estimated to account for US$ 10,846.3 Mn in terms of value by the end of 2027.

Global Hemodynamic Monitoring System Market: Opportunities

The use of the deep-learning method to build certain kinds of prediction model is increasing in the medical field. Therefore, key players in the market can focus on integrating deep-learning method to enhance stroke volume (SV) estimation by arterial blood pressure.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1070

Global Hemodynamic Monitoring System Market: Restraints

However, use of hemodynamic monitoring systems is associated with complications such as dysrhythmias, balloon rupture, knotting of the catheter, infection, pulmonary infarction, pulmonary artery rupture, and deep vein thrombosis, which is expected to hamper growth of the market.

Key Takeaways:

The Pulse Oximeters segment in the global hemodynamic monitoring system market was valued at US$ 718.0 Mn in 2018 and is expected to reach US$ 1,078.6 Mn by 2027 at a CAGR of 13.4% during the forecast period. The growth of the segment is attributed to increasing patient population suffering from chronic diseases. The Invasive Hemodynamic Monitoring segment held dominant position in the global hemodynamic monitoring system market in 2018, accounting for 49.4% share in terms of volume, followed by Non-Invasive Hemodynamic Monitoring, and Minimally Invasive Hemodynamic Monitoring, respectively. Technological advancement and increasing product approvals is anticipated to propel the growth of the segment during the forecast period

Market Trends:

The preference for home care settings compared to hospitals is increasing due to growing concerns over the aging population and relatively high costs incurred during hospitalization of people suffering from chronic illness. Key players in the market are focused on developing single monitoring platform. For instance, in July 2019, Caretaker Medical partnered with Mespere LifeSciences to integrate wireless CNIBP, Cerebral Oximetry, and other non-invasive hemodynamic measurements in a single monitoring platform.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/hemodynamic-monitoring-systems-market-1070

Global Hemodynamic Monitoring System Market: Competitive Landscape

Major players operating in the global hemodynamic monitoring system market include, Edwards Lifesciences Corporation, ICU Medical, Inc., PULSION Medical Systems SE, Koninklijke Philips N.V., General Electric Company, OMRON Corporation, B. Braun Melsungen AG, LIDCO Ltd., Medtronic, Inc., Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical Inc.

Global Hemodynamic Monitoring System Market: Key Developments

In December 2019, Masimo announced that a study published in the Journal of Clinical Monitoring and Computing assessed the accuracy of three hemoglobin (Hb) monitoring methods, including noninvasive, continuous Masimo SpHb.

In November 2019, Saranas, Inc. announced completion of the first U.S. commercial case using the Early Bird Bleed Monitoring System for real-time detection and monitoring of endovascular bleed complications.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1070

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags hemodynamic monitoring systems market , hemodynamic monitoring systems market share , hemodynamic monitoring systems market size
Last Updated March 24, 2021